Background and Aims: Walled-off pancreatic necrosis is a well-known serious adverse event of severe acute pancreatitis. EUS-guided transluminal access followed by direct endoscopic necrosectomy is increasingly used to remove necrosis, with good efficacy and a superior safety profile when compared with surgery. However, a percentage of patients is too critically ill to undergo this procedure or lack an appropriate transluminal window for access. Here we describe the use of percutaneous flexible endoscopic necrosectomy (PEN) with use of standard-sized upper endoscopes and accessories in a retrospective single-institution experience with a video demonstration of 1 patient in the series.
INTRODUCTION
Walled-off pancreatic necrosis (WOPN) is a well-known serious adverse event of severe acute pancreatitis. In many referral centers, EUS-guided transluminal drainage followed by direct endoscopic necrosectomy is increasingly used to remove the necrosis, with good clinical efficacy and a superior safety profile when compared with surgery (mortality rate of 2%-6% vs up to 50%, respectively). 1 However, a percentage of patients is too critically ill to undergo the deep sedation or general anesthesia that is required for this procedure, and others lack an appropriate transluminal window for access, with both situations typically resulting in percutaneous drainage by radiology. Percutaneous drainage typically provides immediate relief with regard to decompressing the fluid aspect of the collection and stabilizing the patient's condition; however, percutaneous catheters rarely result in adequate removal of significant necrosis.
Direct percutaneous flexible endoscopic necrosectomy (PEN) through the established tract with both small and standard-sized endoscopes with CREÔ balloon dilation of the tract has been described, but with limited success. We demonstrate the safety and utility of serial percutaneous drain upsizing to 28F (typically 2-4 exchanges over 2-3 weeks) that allow the use of a standard 8.8-mm upper video endoscope with a 2.8-mm working channel and standard-sized accessories (such as a snare) for mechanical debridement through the established tract. After a clean cavity is achieved, a smaller, more compliant drain is replaced by the endoscopist under fluoroscopy, which is left to gravity drainage until follow-up clinic evaluation with repeated cross-sectional imaging.
The authors propose that this minimally invasive approach offers a safe and effective treatment modality for WOPN and other intra-abdominal fluid collections in appropriately selected patients. Here we review a 23-patient retrospective case series from our institution ( Table 1 ). The video (Video 1, available online at www. VideoGIE.org) highlights 1 patient in the case series.
PATIENT CASE
A 55-year-old man with a significant cardiac history presented to the emergency department with severe acute pancreatitis and systemic inflammatory response syndrome. He further decompensated, and his case was complicated by acute respiratory distress syndrome, septic shock, and a non-ST-segment elevation myocardial infarction. He was intubated, given vasopressors, and transferred to the intensive care unit. CT showed pancreatic inflammation and colonic wall pneumatosis; he therefore required an urgent exploratory laparotomy and left hemicolectomy. The patient remained in critically ill condition for the following 3 weeks, and CT imaging showed progression of a peripancreatic fluid collection (Fig. 1 ). On hospital day 27, because of worsening fevers, tachycardia, tachypnea, and abdominal pain, it was thought that the WOPN was likely infected and treatment was indicated.
The patient's condition was not stable enough to permit endoscopy with deep sedation, and the fluid collection did not appear mature enough for transgastric access and debridement. Consequently, after a multidisciplinary discussion, an interventional radiologist placed a percutaneous drain into the peripancreatic collection, and we planned for serial catheter upsizing for eventual PEN after stabilization. The patient was discharged at week 4 and underwent serial upsizing as an outpatient, concluding with a 28F catheter (Thal-Quick Abscess Drainage Set, Cook Medical, Bloomington, IN, USA).
He was seen for follow-up in clinic 4 weeks after hospital discharge and was found to be febrile, tachycardic, and tachypneic. He was directly admitted to the hospital and underwent PEN the following day. The 28F percutaneous drainage catheter was removed, and a standard 8.8-mm upper flexible endoscope with a 2.8-mm working channel was introduced through the established tract (Fig. 2) into the necrotic cavity. The cavity was lavaged with normal saline, and necrotic debris was progressively removed with a 2-cm stiff polypectomy snare (Fig. 3) . When all necrotic debris was removed, the cavity was lavaged with high-volume normal saline solution, and the 28F catheter was replaced. The patient was instructed to flush the drain with 20 to 50 mL of normal saline solution every 4 hours. A total of 3 procedures were performed, and upon completion of the third debridement and washout, no further necrosis was noted (Fig. 4) . A smaller, more compliant, 14F pigtail drainage catheter (Skater AllPurpose Drainage Catheter, Argon Medical Devices, Frisco, Tex, USA) (Fig. 5) was placed until outpatient follow-up.
At 12 weeks after necrosectomy, the percutaneous drainage catheter was removed because the output was less than 20 mL per day for 3 days, and follow-up crosssectional imaging showed complete resolution of the WOPN (Fig. 6) . No recurrent fluid collections were noted.
CONCLUSION
PEN is a minimally invasive and effective treatment approach to WOPN in patients who are not amenable to transluminal drainage and in whom percutaneous drains have been successfully placed. A brief overview of the 23 patients treated with the PEN techniques described using standardsized upper endoscopes and accessories at our institution is summarized in Table 1 . This approach demonstrates the effectiveness and safety of direct PEN in the treatment of intra-abdominal fluid collections and necrosis in appropriately selected patients. PEN appears to have equivalent efficacy and improved safety when compared with EUSguided transluminal access, which carries a known serious adverse event rate to upward of 25% and a postoperative mortality rate of 2% to 6%. 1-2 More experience and more robust clinical trials will be required to confirm these results and further develop this approach.
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